In humans, genetic variants in the APOA1 –APOC3–APOA4 cluster has been associated with the risk of Alzheimer disease, polycythemia induced gastric injury, and metabolic syndrome42–44. This evidence concerns the gene APOA4 and early-onset autosomal dominant Alzheimer disease.